Detalles de la búsqueda
1.
Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life study.
Dermatol Ther
; 35(6): e15489, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35385202
2.
Effectiveness of anti-interleukin 23 biologic drugs in psoriasis patients who failed anti-interleukin 17 regimens. A real-life experience.
Dermatol Ther
; 34(1): e14584, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33236471
3.
Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study.
Acta Derm Venereol
; 101(3): adv00422, 2021 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33269404
4.
Treatment of severe psoriasis with ixekizumab in a liver transplant recipient with concomitant hepatitis B virus infection.
Dermatol Ther
; 32(3): e12909, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30964590
5.
How effective is ustekinumab in controlling psoriatic arthritis?
Dermatol Ther
; 29(3): 155-9, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26626908
6.
Health-related quality of life and its association with alexithymia and difficulties in emotion regulation in patients with psoriasis.
Compr Psychiatry
; 70: 200-8, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27565774
7.
When the old works better than the new: A case of severe nail psoriasis successfully treated with acitretin after failure of two biologic regimens.
Dermatol Ther
; 33(4): e13615, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32424915
8.
Effectiveness and safety of risankizumab in VEry severe plaque psoriasis: a real-life retrospective study (VESPA-Study).
J Dermatolog Treat
; 35(1): 2358150, 2024 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38777338
9.
Effectiveness of risankizumab for the treatment of psoriatic arthritis: a multicenter, real-world study.
Int J Dermatol
; 2024 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38584311
10.
Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study).
J Dermatolog Treat
; 35(1): 2319304, 2024 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38413097
11.
A case of juvenile pityriasis rubra pilaris type III successfully treated with etanercept.
Dermatol Ther
; 31(1)2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29193567
12.
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study.
Clin Cosmet Investig Dermatol
; 16: 3561-3574, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38107670
13.
The Relationship between Alexithymia and Mental Health Is Fully Mediated by Anxiety and Depression in Patients with Psoriasis.
Int J Environ Res Public Health
; 19(6)2022 03 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35329336
14.
Immunogenicity of three doses of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologics.
Front Med (Lausanne)
; 9: 961904, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36148445
15.
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year.
Expert Opin Biol Ther
; 22(12): 1585-1592, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35708257
16.
A consensus-based approach on the management of patients with both psoriasis and psoriatic arthritis in the dermatological and rheumatological settings in Italy: The ADOI PSO-Amore Project.
Dermatol Reports
; 14(3): 9541, 2022 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36199897
17.
Effectiveness of Systemic Therapies in Patients with Obesity and Psoriasis: A Single-center Retrospective Study.
Acta Dermatovenerol Croat
; 29(2): 88-93, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34477074
18.
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy.
Expert Opin Biol Ther
; 21(9): 1291-1298, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34278889
19.
Ultrasound assessment of enthesis thickness in psoriasis and psoriatic arthritis: A cross-sectional study.
Indian J Dermatol Venereol Leprol
; 85(2): 175-181, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-29547136
20.
Use of Secukinumab in a Cohort of Erythrodermic Psoriatic Patients: A Pilot Study.
J Clin Med
; 8(6)2019 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31159169